Scalper1 News
Americans have unofficially made Memorial Day the kickoff of summer, and it’s going to be a hot one for the drug industry. Between now and Labor Day, five companies are looking at FDA decisions that could launch blockbuster drugs, and make a big impact on their bottom lines. First up will be two drugs from Valeant Pharmaceutical Industries (VRX) and Actavis (ACT) that aim to treat the same condition: irritable bowel syndrome with diarrhea (IBS-D). Scalper1 News
Scalper1 News